Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment

Benzinga 2024-07-03

Views 157

In a significant development in the battle against Alzheimer’s disease, the U.S. Food and Drug Administration (FDA) has approved Eli Lilly's Alzheimer’s treatment, “Kisunla.”

Share This Video


Download

  
Report form
RELATED VIDEOS